DEVICES NEW

How Do Medical Device Software Upgrades Work To Stay Safe And Compliant

Posted on by allwill-admin

Medical device software upgrades sit at the center of modern healthcare technology, blending regulatory compliance, cybersecurity, usability, and clinical performance into a single continuous lifecycle. Understanding how medical device software upgrades work is now essential for manufacturers, hospitals, clinics, and software as a medical device providers because patient safety and regulatory approval depend on getting upgrades right.

What Are Medical Device Software Upgrades

Medical device software upgrades are planned, documented changes that enhance features, improve performance, or adapt to new clinical and regulatory expectations, while updates often focus on fixes, patches, and minor improvements. In practice, upgrade and update programs for medical devices cover bug corrections, cybersecurity patches, algorithm tuning, user interface improvements, interoperability enhancements, and integration with new hospital systems. For both embedded software in a medical device and standalone software as a medical device, every upgrade must follow a controlled software lifecycle process, from concept through release and post‑market monitoring.

A key principle in medical device software upgrades is that nothing is “just an IT change” because even small modifications can affect risk, clinical performance, and labeling. That is why international standards and regulators treat software maintenance, software changes, and post‑market upgrades as regulated activities that require formal assessment, verification, and traceability.

Regulatory Framework For Medical Device Software Upgrades

Regulators view medical device software changes through the lens of patient safety, intended use, and risk. In the United States, the Food and Drug Administration uses guidance on when to submit a new 510(k) for a software change to an existing device to help manufacturers decide if a change requires new clearance or can be handled through design controls. In Europe, manufacturers follow MDR expectations alongside harmonized standards to ensure that software modifications remain within the approved intended purpose and risk profile.

Global frameworks such as IEC 62304 for medical device software lifecycle processes and ISO 14971 for risk management define how to organize software maintenance and change control. These standards require that every software upgrade undergo impact analysis, risk evaluation, regression testing, and documentation updates, including software requirements, design descriptions, verification evidence, and configuration records. For software as a medical device and connected health platforms, regulators increasingly expect clear procedures for frequent updates delivered through cloud services, mobile apps, or web interfaces while maintaining full traceability.

Medical Device Software Lifecycle And Where Upgrades Fit

Medical device software upgrades are one phase in a broader software life cycle that begins long before the first release. The typical medical device software lifecycle includes planning, requirements definition, architecture and design, implementation, verification and validation, release, post‑market surveillance, maintenance, and eventually end‑of‑life. IEC 62304 explicitly treats software maintenance as a lifecycle process, not a one‑off activity, which means upgrade planning must be built in from the start.

During post‑market operation, manufacturers collect feedback, complaint data, incident reports, and cybersecurity alerts that drive decisions about new versions and patches. Those triggers feed into software problem resolution processes, change requests, and maintenance plans that define what upgrades will address. As a result, the upgrade release process is tightly linked to risk management updates, usability engineering, clinical evaluation, and quality management system procedures.

Types Of Medical Device Software Upgrades

Not all medical device software upgrades carry the same risk or regulatory impact, so classifying them is critical:

Minor updates typically include small bug fixes, non‑safety critical improvements, and cosmetic user interface adjustments that do not change clinical performance or intended use. These releases still require testing and documentation but may not trigger additional regulatory submissions if they fall within the approved design envelope.

Major upgrades deliver significant functional changes such as new clinical features, analysis modes, alarms, or connectivity options. They may alter performance specifications, risk controls, or indications for use, which can require new regulatory clearance, additional clinical validation, or updated labeling and training.

Cybersecurity patches address vulnerabilities in operating systems, third‑party libraries, communication protocols, and cloud infrastructure that could affect data integrity, availability, or confidentiality. In many device categories, cybersecurity updates are treated as essential maintenance, and regulators encourage timely deployment with documented risk assessments and patch management strategies.

Algorithm and AI model updates are increasingly common in diagnostic devices, decision support tools, and imaging systems. These upgrades may improve sensitivity, specificity, or workflow but can also shift clinical performance profiles, requiring robust validation, transparency about training data, and mechanisms to monitor real‑world performance.

How Risk Management Guides Software Upgrades

Risk management is the backbone of compliant medical device software upgrades. Before implementing a change, manufacturers perform structured impact and hazard analyses to understand how the modification might affect clinical workflows, failure modes, and risk controls. ISO 14971 processes ensure that risks remain acceptable, risk control measures remain effective, and any new hazards are identified and mitigated.

For every proposed upgrade, teams evaluate whether the risk profile changes significantly, whether new failure modes are introduced, and whether existing control measures, alarms, and safeguards still perform as intended. This can lead to design changes, additional mitigations, or updated instructions for use to keep residual risk at an acceptable level. Risk management files, fault trees, and hazard analyses are then updated so future changes build on an accurate baseline.

Also check:  On-Demand Tremor Therapy Devices Empowering Modern Aesthetic Practices

Change Control And Configuration Management

Medical device software upgrades depend on disciplined change control and configuration management. Manufacturers must maintain a complete record of what changed, why it changed, who approved it, what version is active in each market, and how it was verified. Software configuration management processes assign unique identifiers to software builds, track baselines, and ensure that development, test, and production environments stay in sync.

Change control boards or design review teams review proposed modifications, verify that requirements are clear, confirm alignment with regulatory strategy, and ensure that downstream effects on labeling, training, documentation, and servicing are considered. This controlled change process prevents ad‑hoc, undocumented adjustments that can create audit findings or patient safety risks when devices behave differently than their certified design.

Verification, Validation, And Regression Testing For Upgrades

Before a medical device software upgrade can be released, verification and validation activities must demonstrate that the software meets specifications and remains safe and effective. Verification confirms that the change satisfies defined requirements and integrates correctly into the system architecture. Validation demonstrates that the updated device fulfills its intended use in the clinical context, often involving simulated clinical workflows, usability evaluations, or bench testing.

Regression testing is essential during software upgrades to ensure that existing features still work as intended and that changes do not create unintended side effects. For complex systems, risk‑based test strategies focus on high‑impact functions, interfaces, and safety‑critical components. Automated test frameworks, continuous integration pipelines, and traceability from requirements to tests help organizations maintain consistency across multiple upgrade cycles and device versions.

Deployment Models: Field Upgrades, Remote Updates, And Cloud‑Delivered Changes

Medical device software upgrades can be delivered in several ways, and each method carries technical and regulatory implications. Traditional field upgrades often involve technicians or biomedical engineers installing new firmware or software versions using service tools or removable media at the hospital or clinic. This model offers high control but can be slow and costly, particularly for large installed bases across multiple countries.

Remote updates and over‑the‑air upgrades have become more common in connected devices and software as a medical device platforms. These systems use secure networks to push updates directly to devices, apps, or cloud services, enabling faster deployment of cybersecurity patches and performance enhancements. To support remote upgrades safely, manufacturers must design robust rollback mechanisms, digital signatures, integrity checks, and update logs that satisfy both cybersecurity and quality system expectations.

Cloud‑delivered changes in software as a medical device solutions often involve updates to server‑side algorithms, web portals, or integration APIs used by healthcare providers. While deployment may be centralized, manufacturers still need clear version control, release notes, and impact analysis because clinicians depend on stable, predictable behavior for decision making. Hospitals and regulators expect transparency about when significant changes are rolled out and how those changes affect performance claims and clinical workflows.

Cybersecurity In Medical Device Software Upgrades

Cybersecurity has transformed how medical device software upgrades work, turning maintenance into a continuous process of vulnerability detection, patch development, and secure deployment. Connected infusion pumps, imaging systems, remote monitoring platforms, and wearable devices are now part of hospital networks and often communicate with cloud services, making them potential targets for cyber threats.

A robust cybersecurity strategy for medical device software upgrades includes vulnerability scanning, coordinated disclosure programs, secure coding practices, and incident response procedures. When vulnerabilities are identified, manufacturers evaluate exploitability, potential impact on patient safety, and whether a software patch, configuration change, or labeling update is the appropriate mitigation. Regular security patches, firmware updates, and encryption improvements must be balanced with uptime needs and clinical operations, often requiring close coordination with hospital IT and biomedical engineering teams.

Core Technology Behind Safe Upgrade Mechanisms

Inside a medical device, upgrade mechanisms integrate several technologies to ensure reliability and integrity. Bootloaders and secure update modules manage the installation of new firmware or software images, verifying digital signatures and performing integrity checks before activating upgraded code. Many systems use dual‑bank or A/B partitioning so that if an upgrade fails, the device can revert to a known‑good version without interrupting critical functions.

In software as a medical device and cloud‑based platforms, containerization, microservices, and versioned APIs enable rolling upgrades with minimal downtime. Feature flags and controlled rollouts allow manufacturers to enable new functionality for subsets of users, monitor performance, and roll back if anomalies appear. These technologies work together with logging, monitoring, and audit trails so that every upgrade can be traced, investigated, and explained during audits, inspections, or incident reviews.

How Hospitals And Clinics Manage Device Software Upgrades

From the healthcare provider perspective, medical device software upgrades must fit into busy clinical environments, limited downtime windows, and complex infrastructure. Hospital biomedical engineering teams, IT staff, and clinical leaders collaborate to evaluate vendor notifications, prioritize upgrades, plan maintenance windows, and validate changes in test environments before broad deployment. They also maintain asset inventories and version tracking to know which devices have received which upgrades.

Providers must balance the urgency of cybersecurity patches and safety‑critical updates with operational constraints such as ongoing procedures, diagnostic schedules, and staff availability. Clear communication from manufacturers, including risk summaries, compatibility information, and installation instructions, helps hospitals integrate upgrades into their change management processes. Post‑upgrade, providers often monitor clinical workflows, alarm behavior, and user feedback to confirm that devices perform as expected.

Also check:  How Enhanced Vision Probes Deliver Precision in Aesthetics and Safer Image-Guided Treatments

ALLWILL is redefining B2B medical aesthetics by aligning these upgrade and maintenance realities with a transparent, service‑first model. Through its Smart Center, vendor management system, and inventory platform, ALLWILL helps practitioners manage device sourcing, inspection, repair, and upgrade decisions with data‑driven insight and fully vetted technical support.

Real User Cases And ROI From Medical Device Software Upgrades

Healthcare organizations increasingly measure the return on investment from medical device software upgrades by tracking performance, safety, and operational metrics. A radiology department that upgrades the software on its imaging systems might see faster reconstruction times, improved image quality, and reduced repeat scans, all of which translate into higher patient throughput and lower per‑scan costs. When upgrades also streamline workflows or integrate better with PACS and electronic health records, staff productivity improves and reporting delays decrease.

Cardiology clinics adopting upgraded algorithms in remote monitoring platforms may achieve earlier detection of arrhythmias, fewer false alarms, and reduced readmissions. These changes can yield measurable ROI through lower emergency visits, shorter hospital stays, and improved reimbursement outcomes. In another scenario, applying cybersecurity‑focused software updates across an infusion pump fleet can reduce the risk of network downtime, data breaches, and regulatory penalties, while demonstrating due diligence to patients, regulators, and insurers.

Market Trends In Medical Device Software Upgrades

The medical device software upgrade landscape is shifting toward more frequent, incremental releases, especially for software as a medical device, AI‑enabled diagnostics, and connected devices. Instead of large, infrequent upgrades, organizations are moving to continuous delivery models that provide smaller, more manageable changes with higher transparency. This trend supports faster innovation and quicker response to cybersecurity threats, but it also demands stronger lifecycle management, automation, and regulatory alignment.

Regulatory authorities are increasingly publishing guidance on real‑world performance monitoring, artificial intelligence change control, and transparency in algorithm changes. Manufacturers that invest in modern DevOps practices, automated testing, and robust documentation find it easier to comply with these expectations while scaling their product lines. At the same time, healthcare providers are raising expectations for clear release notes, backward compatibility, and coordinated upgrade schedules that respect clinical operations.

Top Services Supporting Medical Device Software Upgrades

Service Type Key Advantages Typical Rating (Internal Benchmarks) Common Use Cases
Regulatory and quality consulting for software changes Clarifies when a new submission is needed, aligns IEC 62304, ISO 14971, and market requirements Very high satisfaction for manufacturers seeking global market access Used when planning major feature upgrades, AI algorithm changes, or expansions into new regions
Managed upgrade and patch deployment services Standardizes rollout across fleets, reduces downtime, and improves cybersecurity posture Strong ratings from hospitals and large clinic networks Ideal for health systems with thousands of connected devices and limited internal support
Software verification and validation outsourcing Increases test coverage, accelerates regression testing, and adds independent verification High ratings among software as a medical device and digital health companies Applied during major version upgrades, platform migrations, and cloud refactoring
Lifecycle and DevOps platform for medical software Integrates requirements, code, testing, risk, and release workflows in one environment Highly rated by organizations adopting continuous delivery Supports ongoing updates, automated pipelines, and post‑market surveillance integration

These services demonstrate how the medical device ecosystem is professionalizing software upgrade planning, execution, and validation to reduce risk and accelerate innovation.

Competitor Comparison Matrix For Upgrade Strategies

Upgrade Strategy Speed Of Deployment Regulatory Complexity Cybersecurity Strength Operational Impact In Hospitals
Traditional on‑site field upgrades Slow, dependent on technician scheduling Moderate, easier to localize changes Moderate, patch distribution can lag threats High disruption if devices taken out of service
Remote over‑the‑air device updates Fast, scalable across fleets and geographies Higher, requires robust controls and documentation High when combined with signed packages and monitoring Lower impact, can schedule off‑hours and stagger rollout
Cloud and software as a medical device centralized updates Very fast for server‑side changes High, especially for AI model and logic changes High, security can be managed centrally Low direct device disruption but requires strong communication with users
Hybrid upgrade model (field plus remote) Balanced speed with tailored control Variable, can optimize per risk level High if both channels secured Moderate, flexible planning for different device classes

This comparison highlights that there is no single best approach to medical device software upgrades; instead, organizations choose strategies aligned with their risk profile, infrastructure, and product portfolio.

Best Practices For Planning Medical Device Software Upgrades

Effective planning is the foundation of safe and efficient medical device software upgrades. Manufacturers should build roadmaps that align product strategy, regulatory milestones, and post‑market feedback, prioritizing changes by risk and patient benefit. Clear upgrade policies, documented in the quality management system, help teams distinguish between maintenance updates, corrective actions, and enhancements and define appropriate controls for each category.

Engaging early with regulatory affairs, clinical experts, cybersecurity specialists, and usability professionals ensures that the upgrade concept addresses real‑world needs and foreseeable risks. Including hospital customers and clinical users in early discussions about new features and workflows can reveal integration challenges, training needs, and data requirements that might otherwise surface only after release. This collaborative planning approach improves adoption and reduces surprises once upgrades are deployed.

Also check:  How Can Clinics Safely Implement Medical Device Software Upgrades?

Implementation Workflow For Medical Device Software Upgrades

Once a software upgrade is approved conceptually, implementation follows a structured workflow that mirrors initial development but with a stronger focus on impact analysis and backward compatibility. Engineers refine requirements, update design documents, and implement code changes using controlled repositories and branching strategies suited to medical device traceability. Throughout implementation, risk management documents and test plans are updated to reflect new behaviors and potential hazards.

Code reviews, static analysis, and unit tests provide early verification of the modified components, while integration and system tests confirm that the updated software interacts correctly with hardware, networks, and clinical environments. Usability evaluations validate that changes in screens, alerts, and workflows are intuitive and do not introduce new use errors. Before release, the organization performs formal reviews, confirming that documentation, labeling, training materials, and service instructions align with the new version.

Post‑Release Monitoring And Feedback Loops

Medical device software upgrades do not end at release; they continue through active post‑market surveillance. Manufacturers track complaint data, incident reports, service logs, performance analytics, and cybersecurity signals to detect issues that may be related to the upgrade. For software as a medical device platforms, usage metrics and outcome data can reveal whether new features deliver the expected clinical and operational benefits.

These feedback loops support continuous improvement by feeding discoveries back into risk management, requirements, and future upgrade plans. If a post‑upgrade problem is identified, teams initiate corrective and preventive action processes to investigate root causes, implement fixes, and potentially release additional updates. Transparent communication with regulators and customers during these cycles helps maintain trust and demonstrate that safety remains the primary priority.

Future Trends In Medical Device Software Upgrades

The future of medical device software upgrades is moving toward adaptive, data‑driven, and risk‑based models. As artificial intelligence and machine learning become more prevalent in diagnostics, monitoring, and therapy optimization, regulators are exploring frameworks for pre‑approved change control plans that allow certain algorithm updates without requiring a full new submission for every minor refinement. This will require clear boundaries, performance metrics, and monitoring commitments.

Another trend is the convergence of medical device lifecycle management with modern DevOps practices, including automated testing, continuous integration, and deployment pipelines adapted to regulated environments. Organizations that master this blend will be able to deliver frequent, reliable upgrades while maintaining robust documentation and traceability. At the same time, healthcare providers will expect seamless integration of upgrades into their digital ecosystems, with minimal downtime and high transparency about what has changed and why.

Frequently Asked Questions About Medical Device Software Upgrades

How often should medical device software be upgraded
The frequency depends on device risk class, cybersecurity demands, clinical needs, and regulatory commitments, but many organizations now plan regular maintenance releases and targeted patches rather than waiting for large infrequent upgrades.

Do all software changes require new regulatory submissions
No, only certain changes that significantly affect intended use, risk profile, or performance claims typically require new submissions, while smaller updates can be managed through internal design control and documentation.

What is the difference between a software update and a software upgrade in medical devices
Updates often refer to smaller patches and fixes, whereas upgrades usually mean larger changes with new functionality or significant improvements, though both must follow regulated lifecycle and risk management processes.

How do hospitals minimize disruption during device software upgrades
Hospitals use change management processes, test upgrades in controlled environments, schedule installations during low‑activity periods, and work closely with manufacturers to understand risks, downtime, and training needs.

Why is cybersecurity so tightly linked to medical device software upgrades
Because connected devices operate on hospital networks and handle sensitive data, timely cybersecurity patches and secure upgrade mechanisms are essential to prevent exploitation that could jeopardize patient safety or operations.

Strategic CTAs For Different Decision Stages

If you are just beginning to explore how medical device software upgrades work, start by mapping your current device portfolio, software versions, and regulatory obligations so you can see where structured lifecycle processes are missing or inconsistent. This visibility will guide early decisions about which devices need formalized upgrade plans and which can be transitioned gradually.

When you are actively planning upgrades for specific products or hospital fleets, align engineering, regulatory, cybersecurity, and clinical stakeholders around a documented upgrade strategy that defines risk thresholds, deployment models, and communication plans. This alignment prevents last‑minute conflicts and supports smoother regulatory reviews, field deployment, and user adoption.

If you are ready to optimize and scale your medical device software upgrade ecosystem, invest in integrated lifecycle platforms, automated testing, secure update mechanisms, and data‑driven post‑market monitoring. These capabilities will help you deliver faster, safer upgrades that support innovation, strengthen regulatory confidence, and improve patient and provider outcomes across every stage of the device lifecycle.

 

allwill-admin

联系我们|Contact Form

TERMS AND CONDITIONS 

These Terms and Conditions (these “Terms”), together with the attached or accompanying quote page (the “Quote,” collectively, this “Agreement”), exclusively govern the sale by Healthcare Markets, Inc., a Delaware corporation doing business as “Powered by MRP” (“MRP”), and the purchase and use by the buyer set forth on the Quote (“Buyer”), of the equipment (the“Equipment”) and/or services (the “Services”).

        1.  EQUIPMENT AVAILABILITY. Equipment offered for sale by MRP is subject to availability. MRP shall not be liable to Buyer in case of stock outage or unavailability of the Equipment. MRP reserves the right to change the equipment offered for sale at any time and without notice to Buyer. Availability of equipment may be determined when an order is placed, and, if unavailable, MRP will inform Buyer of such unavailability, offer other available equipment as substitution or cancel the order. Such cancelled order will be refunded by MRP to Buyer, except for an order for a Special Order Product, which cannot be cancelled once the order is placed.

        2.  PRICES. Written price quotations on the Quote shall last for ten (10) days from the date issued and then automatically expire, and quoted prices do not include taxes, freight, handling, duty, insurance or other similar charges, which Buyer must pay unless waived in writing by MRP or a valid tax exemption certificate is provided to MRP. Notwithstanding the foregoing, all published prices may be changed by MRP at any time without notice to Buyer.

        3.  TERMS OF PAYMENT. Unless otherwise agreed to on the Quote or in writing by MRP, prepayment in full is required, by bank transfer, cash, credit card or certified check, and where partial pre-payment is permitted, such payment shall be nonrefundable with the balance due net thirty (30) days from the date of invoice. MRP reserves the right to modify or revoke any credit previously extended. Past due balances shall be subject to a service charge of one and one-half percent (1.5%) per month, not to exceed the maximum amount permitted by applicable law. Buyer agrees to pay all fees, charges or other sums payable hereunder, including collection fees incurred, with no right of set-off or reduction of any nature unless approved in writing by an MRP corporate officer (an “MRP Officer”). Buyer hereby grants, and MRP reserves, a purchase money security interest in the Equipment purchased, and in any proceeds thereof, to secure Buyer’s payment obligations hereunder. Buyer shall cooperate fully with MRP to execute such documents and accomplish such filings and/or recordings as MRP may deem necessary for the protection of its interests in the Equipment furnished to Buyer, and in the event Buyer does not aid within a reasonable time after MRP asks Buyer to do so, Buyer hereby authorizes and appoints MRP as Buyer’s attorney-in-fact to execute, deliver and file at any time, any financing statement and/or take any other action permitted by applicable law to perfect, enforce, continue and amend MRP’s security interest in any jurisdiction deemed appropriate by MRP. Buyer agrees that upon nonpayment of any charges due to MRP, MRP may cancel or delay delivery of the Equipment and/or suspend any applicable service coverage, which may resume only when MRP receives payment in full, and the warranty period will continue to run during such time of nonpayment although warranty service will not be available.

        4.  SHIPMENT AND DELIVERY. Delivery dates are estimated, and partial deliveries are allowed. MRP shall not be liable for or in respect of any loss or damage arising from any delay in filling any order, failure to deliver or delay in delivery. No delay in the shipment or delivery of any Equipment relieves Buyer of its obligations under this Agreement, including, without limitation, accepting delivery of any remaining installment(s) of the Equipment, if applicable. Buyer must pay for, and hold MRP harmless from, all shipping, delivery, and insurance expenses unless otherwise agreed in writing by an MRP Officer or otherwise indicated on the Quote. MRP will not assume any liability if MRP selects the shipping methods nor will any carrier be deemed to be MRP’s agent. “Time is of the essence” terms will not apply to orders accepted by MRP. Title and risk of loss of the Equipment shall pass to Buyer, and delivery shall be deemed completed, when the Equipment is delivered to Buyer’s address. Should loss or damage in transit occur, Buyer’s payment obligations will not be affected. Buyer is liable for all costs for MRP’s holding or storing of the Equipment if delivery is delayed by Buyer or at Buyer’s request. If delivery is delayed over thirty (30) days, MRP may, at its option and upon notice to Buyer, cancel that and all future deliveries without further liability or obligation of any kind.

        5.  FORCE MAJEURE. MRP shall not be responsible for delays or failure to render or service any Equipment and/or perform any Service due to any cause beyond MRP’s control, including, but not limited to: (a) acts of God; (b) flood, fire, earthquake, epidemic, pandemic or explosion; (c) war, invasion, hostilities (whether war is declared or not), terrorist threats or act, riot or other civil unrest; (d) government order, law or actions; (e) embargoes or blockades in effect on or after the date of this Agreement; (f) national or regional emergency; (g) strikes, labor stoppages or slowdowns or other industrial disturbances; and (h) telecommunication breakdowns, power outages or shortages, lack of warehouse or storage space, inadequate transportation services or inability or delay in obtaining supplies of adequate or suitable material (each, a “Force Majeure Event”). Any delivery date may be extended, at MRP’s sole discretion, to the extent of any delay resulting from any Force Majeure Event.

        6.  ACCEPTANCE; INSPECTION. Except for Special Order Products, Buyer shall inspect all Equipment upon delivery and within forty-eight (48) hours of delivery to Buyer shall give written notice to MRP of any error or claim that any Equipment does not conform to the terms of this Agreement; any claims not made within such period shall be deemed waived and released, with the Equipment being accepted by Buyer. Except as provided under this Section 6 and Section 7 hereof, all sales of Equipment to Buyer are made on a one-way basis, and Buyer has no right to return Equipment purchased under this Agreement to MRP. Subject to the warranty set forth in Section 8(c)(iv), Services are deemed to be accepted by Buyer upon completion of their performance by MRP.

        7.  CANCELLATION CHARGES AND RETURNED EQUIPMENT POLICY. Returns and cancellations are not permitted without written approval by an MRP Officer, which shall be made in such MRP Officer’s sole discretion. If approved, MRP will issue a return merchandise authorization number, which Buyer must include in the returned packaging, and Buyer must pay MRP either a (a) twenty percent (20%) restocking charge on the purchase price of the item if Buyer’s written request for return or cancellation is received by MRP’s headquarters after MRP’s original shipment of the Equipment or (b) a ten percent (10%) cancellation damages charge if Buyer’s request was received before said shipment. The foregoing charges are agreed upon, not as a penalty, but because of the difficulty of computing actual damages, and until the applicable charge is paid and the Equipment has been received back by MRP in new condition, no refund will be given. This document or copies hereof may be filed with the appropriate authorities as a financing statement to pursue such charges. In no case will shipping and freight costs be refunded. Removed, replaced or substituted equipment and parts (collectively, “Returned Equipment”) shall become MRP’s property, with title and ownership transferring to MRP upon the earlier of its return or replacement, with MRP owing no other obligations on the Returned Equipment. Buyer hereby agrees to indemnify, defend and hold harmless MRP Indemnitees from any claims, costs, losses, attorneys’ fees and expenses related to any third-party attempts to claim ownership of the Returned Equipment or dispute any trade-in, removal, substitution or replacement, and the remaining provisions shall continue in full force and effect.

        8.  MRP’S WARRANTIES, IF ANY.

(a) Equipment Sold “As Is.” UNLESS OTHERWISE STATED ON THE QUOTE OR IN A WRITING SIGNED BY AN MRP OFFICER, BUYER AGREES THAT THE EQUIPMENT SOLD IN THIS AGREEMENT IS BEING SOLD ON AN “AS IS,” “AS AVAILABLE” BASIS, SUBJECT TO SECTIONS 8(c) AND 9, AND HAVE NO WARRANTIES OR REPRESENTATIONS OF ANY KIND, WHETHER IMPLIED OR ARISING BY LAW, STATUTE OR OTHERWISE, INCLUDING, WITHOUT LIMITATION, ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR USE, NON-INFRINGEMENT, WORKMANLIKE MANNER, QUALITY, ACCURACY, TITLE, AND/OR IMPLIED FROM A COURSE OF DEALING OR PERFORMANCE USAGE IN TRADE.

(b) Special Order Product. If this Agreement includes the sale of a product that MRP does not currently have or typically keep in stock, in MRP’s sole determination, but is acquired from a third party specifically for Buyer (a “Special Order Product”), then Buyer agrees that (i) Buyer, at its sole discretion, has made the selection of such Special Order Product, (ii) such Special Order Product is being acquired by MRP solely at the request of Buyer, (iii) no representation, warranty or guarantee has been made by MRP with respect to such Special Order Product, (iv) the obligation of Buyer to pay MRP for the Special Order Product is absolute and unconditional, and (v) Buyer waives and releases MRP from all claims, damages and losses arising out of such Special Order Product. Special Order Products carry no right to inspection before or after delivery, and MRP is not responsible for examining or evaluating such Special Order Products. MRP makes no warranty about Special Order Products and offerings of the third party (including description of the Special Order Product). MRP does not assume any responsibility or liability for the actions, product and content of all these and any other third parties. If there are any problems with any Special Order Product, Buyer must contact the manufacturer of such Special Order Product for assistance.

(c) Limited Warranties, If Any.

(i) If the Quote expressly states that the Equipment has a warranty for a certain time (a “Warranty Period”), then MRP warrants that the Equipment shall be in good working order under normal use for the Warranty Period, which Warranty Period shall commence from the date of delivery to Buyer (the “Delivery Date”), unless otherwise approved by an MRP Officer in writing, except for the following: (A) New (not used or pre-owned) Equipment that is to be serviced by MRP: if the Quote is silent, warranted to be in good working order under normal use for one hundred eighty (180) days from the Delivery Date; (B) Used Equipment sold refurbished by MRP: if the Quote is silent, warranted to be in good working order under normal use for thirty (30) days from the Delivery Date; (C) Consumable/disposable Equipment: if the Quote is silent, warranted to have been shipped from MRP in functional condition, and no additional warranty shall apply; no service shall be provided either. These items should be inspected for obvious damage, subject to Section 6 and 8(e), and MRP’s obligation under this warranty and this Section 8(c)(i)(C) is limited to replacement of the Equipment; and (D) New (not used or pre-owned) Equipment that is to be serviced by the manufacturer: if the Quote is silent, MRP makes no warranty for any such Equipment. Buyer’s sole warranty for any such Equipment, if any, shall be the original manufacturer’s warranty, which MRP agrees to pass on to Buyer, as applicable. (ii) For the limited warranties of Section 8(c)(i), including exceptions (A) and (B), but not (C) or this (D), Buyer is entitled to telephone, e-mail and video technical assistance and, subject to Sections 8(d) and 8(e), repair or replacement of such Equipment, in MRP’s sole discretion, should the Equipment become inoperative through normal use during the Warranty Period. Loaner equipment is not provided, but if so arranged by MRP, Buyer shall pay MRP the cash list price of any unreturned loaner equipment provided by MRP within seven (7) days of a written demand from MRP. (iii) Repair or replacement under any limited warranty of Equipment may be with parts or products that are new, used or refurbished, carrying the same limited warranty for the remaining term of the original item. Repairs or replacements shall not interrupt, extend or prolong the term of the warranty. (iv) For Services purchased under this Agreement, MRP warrants that the Services shall be performed using competent personnel in a professional manner in accordance with generally recognized industry standards for similar services. Subject to Sections 6 and 8(e) herein, if any Service was not performed in accordance with the aforementioned warranty, then MRP shall, in its sole discretion, either (A) repair or re-perform the applicable Service, or (B) credit or refund the price of such Service at the pro rata contract rate.

(d) Exclusions. MRP reserves the right, without liability, to void all warranties and remedies, including any obligation to service, repair, replace or otherwise remedy defects, errors or failures of the Equipment due to the occurrence of any of these events, and MRP shall be in no way responsible for: (i) handling, maintenance or use in a manner that is inconsistent with and/or contrary to the original manufacturer’s or MRP’s recommended procedures and/or instructions, including, without limitation, use of or with an unauthorized third-party good or part; (ii) any failure or damage resulting from negligence, alteration, modification or relocation of the Equipment by Buyer, its employees, agents or representatives; (iii) attempted or actual unauthorized dismantling, disassembling, service, repair, addition or change of the Equipment, including, without limitation, changing the serial number or shot count; (iv) abnormal wear and tear, including, without limitation, use under abnormal conditions (e.g., unclean, dusty, or exposure to extreme electromagnetic radiation, temperature or humidity); or (v) damage or failure of the Equipment due to a Force Majeure Event or a problem in the premises of the Equipment. In any of the above situations, or for any Equipment that has no warranty, MRP has sole discretion to service the Equipment, at Buyer’s expense, at MRP’s then-in-effect rates for service, labor, travel, shipping and materials.

(e) Notice and Inspection. The limited warranties contained in this Section 8 are made on condition that immediate written notice of any noncompliance with the Equipment’s and/or the Service’s warranty be given to MRP, and provided that MRP’s inspection reveals that Buyer’s claim is valid under the terms of such warranty.

        9.  DISCLAIMERS; NO OTHER WARRANTY. EXCEPT TO THE EXTENT AS PROVIDED IN SECTION 8(c)(i)(D), BUYER ACKNOWLEDGES THAT MRP IS NOT BOUND BY ANY WARRANTY THAT MAY BE SET FORTH IN A MANUFACTURER’S WRITTEN MATERIALS THAT WOULD HAVE APPLIED HAD BUYER PURCHASED THE EQUIPMENT DIRECTLY FROM THE MANUFACTURER IN ITS UNUSED STATE. BUYER ACKNOWLEDGES THAT BUYER HAS NOT RELIED UPON ANY WARRANTY OTHER THAN AS SET FORTH IN THIS AGREEMENT. IN ADDITION, BUYER ALSO HEREBY ACKNOWLEDGES AND AGREES THAT ANY ORAL OR WRITTEN STATEMENTS CONCERNING USE AND REGULATION OF MEDICAL DEVICES SOLD BY MRP ARE AND SHALL BE CONSTRUED AS FOR INFORMATIONAL PURPOSES ONLY AND WITHOUT WARRANTY OR ASSURANCE BY MRP AS TO THEIR ACCURACY OR VALIDITY. MRP ALSO HEREBY DISCLAIMS ANY AND ALL WARRANTIES REGARDING OTHER MEDICAL CARE OR HELP, INCLUDING THE SELECTION OF AESTHETIC AND MEDICAL PROCEDURES AND PRODUCTS FOR, OR CARE OF, PATIENTS. THE LIMITED WARRANTIES OF THIS AGREEMENT, IF APPLICABLE TO ANY EQUIPMENT OR SERVICE FURNISHED UNDER THIS AGREEMENT, CONSTITUTE THE ONLY WARRANTIES MADE WITH RESPECT TO THE EQUIPMENT AND/OR SERVICE AND ANY DEFECT, DEFICIENCY OR NONCONFORMITY. TO THE EXTENT PERMITTED BY LAW, SUCH WARRANTY IS IN LIEU OF ALL OTHER WARRANTIES, EXPRESS OR IMPLIED BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE, INCLUDING, BUT NOT LIMITED TO, ANY EXPRESS OR IMPLIED WARRANTY OF MERCHANTABILITY, TITLE, NONINFRINGEMENT OR FITNESS FOR A PARTICULAR PURPOSE.

        10.  LIMITATION OF LIABILITY. NOTWITHSTANDING ANYTHING TO THE CONTRARY IN THIS AGREEMENT, UNDER NO CIRCUMSTANCES SHALL MRP BE LIABLE FOR ANY INDIRECT, PUNITIVE, INCIDENTAL, CONSEQUENTIAL, EXEMPLARY OR SPECIAL DAMAGES, ARISING FROM, RELATED TO OR CAUSED, DIRECTLY OR INDIRECTLY, WHETHER FORESEEABLE OR NOT, BY THE EQUIPMENT AND/OR THE SERVICES, THE USE OR INABILITY TO USE THE EQUIPMENT, THE RESULTS GENERATED FROM THE EQUIPMENT AND/OR THE SERVICES, THIS AGREEMENT, ANY OTHER ACT OR OMISSION OF MRP, OR BASED UPON ANY OTHER LEGAL THEORY. IN NO EVENT SHALL MRP BE LIABLE FOR ANY LOSSES OF REVENUE, USE, BUSINESS OPPORTUNITY, PROFIT, SAVINGS OR ANY OTHER DAMAGES DUE TO ANY CAUSE WHATSOEVER, EVEN IF MRP OR ITS AGENTS HAS BEEN ADVISED OF THE POSSIBILITY THEREOF. THE FOREGOING IS A SEPARATE, ESSENTIAL TERM OF THIS AGREEMENT, AND SHALL BE EFFECTIVE UPON THE FAILURE OF ANY REMEDY, EXCLUSIVE OR NOT. IN NO EVENT WILL MRP’S TOTAL LIABILITY UNDER THIS AGREEMENT EXCEED THE PURCHASE PRICE ACTUALLY PAID TO MRP BY BUYER FOR THE EQUIPMENT AND/OR THE SERVICES GIVING RISE TO THE CLAIM FOR WHICH DAMAGES ARE BEING SOUGHT. NO SUIT OR ACTION MAY BE BROUGHT BY BUYER, ITS SHAREHOLDERS, DIRECTORS, MANAGERS, EMPLOYEES OR AGENTS FOR ANY BREACH OF THIS AGREEMENT MORE THAN ONE (1) YEAR AFTER THE ACCRUAL OF SUCH CAUSE OF ACTION. IT IS AGREED THAT MRP’S LIABILITY IS SO LIMITED. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, BUYER ASSUMES ALL RISK AND LIABILITY FOR THE RESULTS OBTAINED BY THE USE OF ANY EQUIPMENT IN THE PRACTICE OF ANY PROCESS, WHETHER IN TERMS OF OPERATING COSTS, GENERAL EFFECTIVENESS, SUCCESS OR FAILURE, AND REGARDLESS OF ANY ORAL OR WRITTEN STATEMENTS MADE BY MRP, BY WAY OF TECHNICAL ADVICE OR OTHERWISE, RELATED TO THE USE OF THE EQUIPMENT.

        11.  BUYER’S REPRESENTATIONS AND WARRANTIES. Buyer represents and warrants to MRP that: (a) Buyer is duly organized, validly existing, and in good standing in the jurisdiction of Buyer’s formation; (b) Buyer is duly qualified to do business and is in good standing in every jurisdiction in which such qualification is required; (c) Buyer has the full right, power, and authority to enter into this Agreement and to perform Buyer’s obligations under this Agreement; (d) the execution of this Agreement by the person whose signature is set forth at the end hereof has been duly authorized by all necessary corporate action of Buyer; (e) when executed and delivered by each of MRP and Buyer, this Agreement will constitute the legal, valid and binding obligation of Buyer, enforceable against Buyer in accordance with its terms; (f) Buyer is in compliance with all applicable laws relating to this Agreement, the Equipment and the operation of Buyer’s business; (g) Buyer is not insolvent and is paying all of its debts as they become due; and (h) all financial information that Buyer has provided to MRP is true and accurate and fairly represents Buyer’s financial condition.

        12. PROPRIETARY RIGHTS.

(a) Ownership. No sale shall be construed as granting to Buyer any license or other right in, or to, any of MRP’s (i) patents; (ii) trademarks; (iii) internet domain names, whether or not trademarks, registered by any authorized private registrar or governmental authority, web addresses, web pages, websites and URLs; (iv) works of authorship, expressions, designs and design registrations, whether or not copyrightable, including copyrights and copyrightable works, software and firmware, technical data, data files, and databases and other specifications and documentation; (v) trade secrets; (vi) environmental or other testing applicable to the Equipment and/or the Services; and (vii) industrial and other intellectual property rights, and all rights, interests, and protections that are associated with, equivalent or similar to, or required for the exercise of, any of the foregoing, however arising, in each case whether registered or unregistered and including all registrations and applications for, and renewals or extensions of, such rights or forms of protection pursuant to the laws of any jurisdiction throughout in any part of the world (collectively, the “Intellectual Property Rights”).

(b) Prohibited Acts. Buyer shall not (i) take any action that might interfere with any of MRP’s rights in or to Intellectual Property Rights, including MRP’s ownership or exercise thereof; (ii) challenge any right, title, or interest of MRP in or to the Intellectual Property Rights; (iii) make any claim or take any action adverse to MRP’s ownership of the Intellectual Property Rights; (iv) register or apply for registrations, anywhere in the world, for MRP’s trademarks or any other trademark that is similar to MRP’s trademarks or that incorporates MRP’s trademarks in whole or in confusingly similar part; (v) use any mark, anywhere that is confusingly

similar to MRP’s trademarks in whole or in confusingly similar part; (vi) engage in any action that tends to disparage, dilute the value of or reflect negatively on the Equipment and/or the Services or any of MRP’s trademarks; (vii) misappropriate any of MRP’s trademarks for use as a domain name without prior written consent from MRP; or (viii) alter, obscure or remove any of MRP’s trademarks, or trademark or copyright notices or any other proprietary rights notices placed on the

Equipment, marketing materials or other materials that MRP may provide.

        13.  CONFIDENTIAL INFORMATION. Without the prior written consent of MRP,Buyer, directly or indirectly, shall not disclose (and will direct its directors, shareholders, employees and agents not to disclose) any Confidential Information. The term “Confidential Information” means any information of or relating to MRP or the Equipment and/or the Services not generally known to the public (other than as a result of disclosure in violation of this Agreement) in spoken, printed, electronic or any other form or medium, including, but not limited to, business processes, practices, methods, policies, plans, publications, documents, research, operations, services, strategies, techniques, agreements, contracts, transactions, potential transactions, know-how, trade secrets, databases, manuals, records, supplier information, financial information, accounting information, legal information, marketing information, pricing information, payroll information, personnel information, and supplier lists.

        14.  NON-SOLICITATION. Buyer agrees not to solicit or hire any personnel of MRP involved with the delivery of the Services during the provision of such Services and for twelve (12) months after the completion of such Services; provided, however, that Buyer may hire individuals employed by MRP who, without other solicitation, respond to advertisements or solicitations aimed at the general public.

        15.  EQUITABLE REMEDIES. Buyer acknowledges and agrees that (a) a breach or threatened breach by Buyer of any of its obligations under Sections 13 or 14 would give rise to irreparable harm to MRP for which monetary damages would not be an adequate remedy and (b) in the event of a breach or a threatened breach by Buyer of any such obligations, MRP shall, in addition to any and all other rights and remedies that may be available to MRP at law, at equity, or otherwise in respect of such breach, be entitled to equitable relief, including a temporary restraining order, an injunction, specific performance, and any other relief that may be available from a court of competent jurisdiction, without any requirement to post a bond or other security, and without any requirement to prove actual damages or that monetary damages will not afford an adequate remedy. Buyer agrees that Buyer will not oppose or otherwise challenge the appropriateness of equitable relief or the entry by a court of competent jurisdiction of an order granting equitable relief, in either case, consistent with the terms of this Section 15.

        16.  INDEMNIFICATION. Buyer agrees to indemnify, defend and hold harmless MRP and its directors, shareholders, employees and agents (collectively, “MRP Indemnitees”) against any liability, damage, loss or expense incurred by or imposed in connection with any claims, suits, actions, demands or judgments arising out of (a) any breach or non-fulfillment of any representation, warranty or covenant set forth in this Agreement by Buyer or its directors, managers, employees or agents (collectively, “Buyer’s Agents”); (b) any negligent act or omission or willful misconduct of Buyer or Buyer’s Agents in connection with this Agreement; (c) any bodily injury, death of any person or damage to real or tangible personal property caused by Buyer or Buyer’s Agents, including the use of unauthorized parts in or service of the Equipment; (d) any failure by Buyer or Buyer’s Agents to comply with any applicable laws; (e) any fraud or other intentional acts by Buyer or Buyer’s Agents; and (f) the use or operation of the Equipment, including, without limitation, any medical and/or surgical procedures performed by Buyer, and any of Buyer’s Agents, using the Equipment unless said damages are determined by a court of competence jurisdiction to be solely by the gross negligence of MRP or solely as result of a breach by MRP of the limited warranties contained herein.

        17.  DEFAULTS; REMEDIES. Notwithstanding anything herein to the contrary, should Buyer fail to pay for the order or any other amount, in whole or in part, when due or perform its other obligations under this Agreement or as otherwise mutually agreed in writing between Buyer and MRP (each, a “Default”), then MRP may take any and all actions available under law or equity to collect said amounts with a ten (10) day prior written notice, including, but not limited to, enforcing its security interest, accelerating the payment of and declaring immediately due and payable any unpaid balance of the order, referral to outside collection agencies and/or commencement of legal action. MRP’s rights shall be cumulative, and it shall not be required to have attempted to realize upon to the Equipment before taking any other collection actions. MRP may require that Buyer assemble and return any or all of the Equipment to MRP and, in the event Buyer fails to return such Equipment peaceably, enter upon the premises where such Equipment is located, with or without legal process, and repossess such Equipment. Upon a Default, Buyer agrees to pay upon MRP’s demand: (i) all costs and expenses incurred by MRP or its assignee in connection with the enforcement of any remedies, including all expenses incurred in connection with the return, sale, release or other disposition of the Equipment, including attorneys’ fees and other costs incurred by MRP or its assignee in enforcing or defending its rights and remedies under this Agreement and any other written agreement between Buyer and MRP.

        18.  COMPLIANCE WITH LAWS. Buyer shall (a) carry out the transactions contemplated by this sale and deal with the Equipment in conformity with all applicable laws, rules and regulations of all government authorities, including, without limitation, export laws, (b) obtain all permits and licenses required in connection with the purchase, shipment, installation or use of the Equipment, and (c) be solely responsible to fully understand and comply with laws, rules and regulations. Any information provided is as a convenience only.

        19.  FURTHER ASSURANCES. Upon MRP’s reasonable request, Buyer shall, at its sole cost and expense, execute and deliver all such further documents and instruments, and take all such further acts, necessary to give full effect to this Agreement.

        20.  ASSIGNMENT; SUCCESSORS AND ASSIGNS. Buyer cannot delegate any duties nor assign any rights or claims under this Agreement without MRP’s prior written consent, and any such attempt or assignment shall be void. In the event that Buyer finances its acquisition of any Equipment with a third party, Buyer may direct MRP to transfer title of such Equipment to such third-party financing company, with all remaining terms and conditions of this Agreement remaining in full force and effect. This Agreement is binding on and inures to the benefit of the parties to this Agreement and their respective permitted successors and permitted assigns.

        21.  NO THIRD-PARTY BENEFICIARIES. Subject to Section 16, this Agreement benefits solely the parties to this Agreement and their respective permitted successors and assigns, and nothing in this Agreement, express or implied, confers on any other person any legal or equitable right, benefit, or remedy of any nature whatsoever under or by reason of this Agreement.

        22.  GOVERNING LAW; VENUE. The application of the UN Convention on Contracts for the International Sale of Goods is expressly excluded. The parties agree that any and all claims, demands, disagreements, controversies or disputes arising out of or relating to this Agreement and any agreement or document delivered in connection herewith (collectively, “Claims”) shall be governed by and construed in accordance with the laws of the State of Utah and adjudicated exclusively in the state and federal courts located in or nearest to Summit County, Utah, which courts shall have the sole and exclusive jurisdiction and venue for adjudication of all Claims. The parties hereby agree upon, consent and stipulate to the jurisdiction and venue of the aforementioned courts for the adjudication of all Claims, to the exclusion of all other courts, forums and venues whatsoever.

        23.  NON-DISPARAGEMENT. Buyer shall not disparage MRP or MRP’s trademarks, websites, products or services, or display any such items in a derogatory or negative manner on any website or in any public forum or press release.

        24.  NOTICES. Any notice, demand, or communication required, permitted or desired to be given hereunder shall be deemed effectively given when personally delivered, when sent by electronic means, when received by overnight courier, or when mailed by prepaid, certified or registered mail, return receipt requested, addressed to the other party at its address set forth on the Quote or to such other address that the receiving party may designate from time to time in accordance with this Section 25.

        25.  PUBLIC ANNOUNCEMENTS. Unless otherwise stated herein, neither party shall issue a press release or otherwise advertise, make a public statement or disclose to any third-party information pertaining to the relationship arising under this Agreement, the existence or terms of this Agreement, the underlying transactions between MRP and Buyer or agent for Buyer or refer to the other party in relation to this Agreement without the other party’s prior written approval.

        26.  ENTIRE AGREEMENT; ADDITIONAL OR INCONSISTENT TERMS. Subject to Section 32, this Agreement constitutes the sole and entire agreement between the parties hereto relating to the subject matter hereof, and any unincorporated representation, affirmation of fact, course of prior dealings, promise or condition in connection therewith, or usage of the trade, shall not be binding on either party. Terms and conditions set forth which differ from, conflict with or are not included in this Agreement shall not be part of any agreement between MRP and Buyer unless both parties specifically accept such terms and conditions in writing.

        27.  WAIVER. No waiver under this Agreement is effective unless it is in writing and signed by the party waiving its right. Any waiver authorized on one occasion is effective only in that instance and only for the purpose stated and does not operate as a waiver on any future occasion. None of the following constitutes a waiver or estoppel of any right, remedy, power, privilege or condition arising from this Agreement: any failure or delay in exercising any right, remedy, power or privilege or in enforcing any condition under this Agreement; or any act, omission or course of dealing between the parties.

        28.  SURVIVAL. Subject to the limitations and other provisions of this Agreement, the representations and warranties of Buyer contained herein shall survive the expiration or earlier termination of this Agreement for a period of twelve (12) months after such expiration o termination and (b) this Section 29 and Sections 10, 12, 13, 14, 15, 16, 17, 21, 22, 23, 24, 26, and 32 of this Agreement, as well as any other provision that, in order to give proper effect to its intent, should survive such expiration or termination, shall survive the expiration or earlier termination of this Agreement. All other provisions of this Agreement shall not survive the expiration or earlier termination of this Agreement.

        29.  RELATIONSHIP OF PARTIES. Nothing in this Agreement creates any agency, joint venture, partnership or other form of joint enterprise, employment or fiduciary relationship between the parties. Neither party has any express or implied right or authority to assume or create any obligations on behalf of or in the name of the other party or to bind the other party to any contract, agreement or undertaking with any third party.

        30.  HEADINGS. The headings in this Agreement are for reference only and do not affect the interpretation of this Agreement.

        31.  ORDER OF PRECEDENCE. In the event of conflict between the Quote, a written agreement by MRP, and these Terms, the order of priority shall be: (1) the written

agreement by MRP, if only if executed by an MRP Officer, (2) the Quote and (3) these Terms, and only to the extent of the direct conflict. Notwithstanding the foregoing, MRP shall not be bound by, and specifically objects to, any terms, conditions or other provisions, both written and oral, which are different from, in addition to or inconsistent with the provisions of this Agreement which are set forth in any purchase order, receipt, acceptance, confirmation, correspondence or otherwise of, or by, Buyer. Fulfillment of Buyer’s order shall not constitute acceptance of any of Buyer’s terms and conditions and does not serve to modify or amend the terms and conditions contained herein.

        32.  SEVERABILITY. If any part of this Agreement is held to be void, illegal or unenforceable, then it shall be deemed to be severed from this Agreement and the remaining provisions shall continue in full force and effect; provided, however, that if any fundamental term or provision of this Agreement is held to be void, illegal or unenforceable, the remainder of this Agreement shall be unenforceable. Upon a determination that any term or provision is void, illegal or unenforceable, the parties shall negotiate in good faith to modify this Agreement to effect the original intent of the parties as closely as possible in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible.